Product Code: NF12-01-00-00-00
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-invasive technologies is disrupting this market space as it reduces patient pain points while providing accurate and sensitive results. Due to more hospital-centric care in the EU region, the POCT segment here experiences stronger growth than in the United States. POCT has the potential to grow the fastest due to its efficient, cost-effective solution and increasing adoption by physicians.
Key Questions this Study will Answer
- What is the diabetes diagnostics market scenario in Europe and the United States?
- How are the large exiting participants going to change this market?
- Which are the major market segments, and what are the important trends that could affect market direction?
- Who are the key market participants involved in each segment? What are their best practices in this market?
- What are the key changes in the diabetes policy system of different regions in Europe and the United States and how will they affect the market in the future?
- What is the future of the diabetes diagnostics market in Europe and the United States, and what should market participants do to succeed?
Table of Contents
1. EXECUTIVE SUMMARY
Executive Summary
- 1. Key Findings
- 2. Key Findings (continued)
- 3. Key Findings (continued)
- 4. Scope and Segmentation
- 5. Key Questions this Study will Answer
- 6. Measurements
- 7. CEO's Perspective
- 8. Key Companies to Watch
- 9. Executive Summary-3 Big Predictions
2. MARKET OVERVIEW
Market Overview
- 1. Introduction to Diabetes
- 2. Market Overview
- 3. Market Segmentation
- 4. Segment Life Cycle Analysis
- 5. Market Segmentation
- 6. Competitive Segment Analysis
- 7. Defining Healthcare Trends in the Future
3. COMPETITIVE PLAYBOOK
Competitive Playbook
- 1. Diabetes Diagnostics Market-Competitive Landscape
- 2. New Market Opportunities
- 3. New Market Opportunities (continued)
- 4. Competitive Analysis
- 5. Competitive Analysis (continued)
- 6. Competitive Analysis (continued)
- 7. Competitive Analysis (continued)
- 8. Competitive Analysis (continued)
4. TOTAL MARKET ANALYSIS
Total Market Analysis
- 1. Measurements
- 2. Forecast Assumptions
- 3. Revenue Forecast
- 4. Segment Overview
- 5. Revenue Forecast by Segment
- 6. Revenue Forecast Discussion
5. US ANALYSIS
US Analysis
- 1. Market Drivers
- 2. Drivers Explained
- 3. Drivers Explained (continued)
- 4. Market Restraints
- 5. Restraints Explained
- 6. Measurements
- 7. US Revenue Forecast
- 8. Segment Overview
- 9. Revenue Forecast by Segment
- 10. Revenue Forecast Discussion
6. US SMBG SEGMENT
US SMBG Segment
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Segment
- 4. Revenue Forecast Discussion
- 5. Market Share Analysis
- 6. Market Share Analysis (continued)
7. US POCT SEGMENT
US POCT Segment
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Segment
- 4. Revenue Forecast Discussion
- 5. Market Share Analysis
8. US LAB-BASED TESTING SEGMENT
US Lab-based Testing Segment
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast Discussion
- 4. Market Share Analysis
- 5. Lab-based Testing Trends
- 6. Comparison of Lab-based Tests
- 7. Comparison of Lab-based Tests (continued)
9. EUROPE ANALYSIS
Europe Analysis
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Region
- 4. Revenue Forecast Discussion
- 5. Segment Overview
10. EUROPE SMBG SEGMENT
Europe SMBG Segment
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Segment
- 4. Revenue Forecast Discussion
- 5. Market Share Analysis
11. EUROPE POCT SEGMENT
Europe POCT Segment
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Segment
- 4. Revenue Forecast Discussion
- 5. Market Share Analysis
12. EUROPE LAB-BASED TESTING SEGMENT
Europe Lab-based Testing Segment
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast Discussion
- 4. Market Share Analysis
- 5. Lab-based Testing Segment Trends
- 6. Comparison of Lab-based Tests
- 7. Comparison of Lab-based Tests (continued)
13. EUROPE-REGIONAL ANALYSIS
Europe-Regional Analysis
- 1. Regional Overview
- 2. Revenue Forecast-The United Kingdom
- 3. UK Regulations and Reimbursements
- 4. Revenue Forecast by Segment-The United Kingdom
- 5. UK Revenue Forecast Discussion
- 6. UK Revenue Forecast Discussion (continued)
- 7. UK Revenue Forecast Discussion (continued)
- 8. UK Revenue Forecast Discussion (continued)
- 9. Market Impact of Top 10 Trends
- 10. Revenue Forecast-Germany
- 11. Germany Reimbursements and Regulations
- 12. Revenue Forecast by Segment-Germany
- 13. Germany Revenue Forecast Discussion
- 14. Germany Revenue Forecast Discussion (continued)
- 15. Market Impact of Top 10 Trends
- 16. Revenue Forecast-France
- 17. France Reimbursements and Regulations
- 18. France Reimbursements and Regulations (continued)
- 19. Revenue Forecast by Segment-France
- 20. France Revenue Forecast Discussion
- 21. France Revenue Forecast Discussion (continued)
- 22. France Revenue Forecast Discussion (continued)
- 23. Market Impact of Top 10 Trends
- 24. Revenue Forecast-Italy
- 25. Italy Reimbursements and Regulations
- 26. Revenue Forecast by Segment-Italy
- 27. Italy Revenue Forecast Discussion
- 28. Italy Revenue Forecast Discussion (continued)
- 29. Market Impact of Top 10 Trends
- 30. Revenue Forecast-Spain
- 31. Spain Reimbursements and Regulations
- 32. Revenue Forecast by Segment-Spain
- 33. Spain Revenue Forecast Discussion
- 34. Spain Revenue Forecast Discussion (continued)
- 35. Market Impact of Top 10 Trends
- 36. Revenue Forecast-Benelux (Belgium, the Netherlands, Luxembourg)
- 37. Benelux Reimbursements and Regulations
- 38. Benelux Reimbursements and Regulations (continued)
- 39. Revenue Forecast by Segment-Benelux
- 40. Benelux Revenue Forecast Discussion
- 41. Revenue Forecast-Scandinavia
- 42. Scandinavia Reimbursements and Regulations
- 43. Revenue Forecast by Segment-Scandinavia
- 44. Scandinavia Revenue Forecast Discussion
- 45. Market Impact of Top 10 Trends
14. KEY COMPANIES TO WATCH
Key Companies to Watch
- 1. HemoCue
- 2. NovioSense
- 3. Miraculins
15. THE LAST WORD
The Last Word
- 1. The Last Word-3 Big Predictions
16. APPENDIX
Appendix
- 1. Additional Studies of Interest
- 2. Additional Studies of Interest (continued)
- 3. Methodology
- 4. List of Exhibits
- 5. List of Exhibits (continued)
- 6. List of Exhibits (continued)
- 7. List of Exhibits (continued)
- 8. List of Exhibits (continued)
- 9. List of Exhibits (continued)
- 10. List of Exhibits (continued)
- 11. List of Exhibits (continued)
List of Exhibits
- Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
- Total Diabetes Diagnostics Market: Percent Prevalence of Diabetes, Global, 2014
- Total Diabetes Diagnostics Market: Market Segmentation, US and Europe, 2014
- Total Diabetes Diagnostics Market: Segment Life Cycle Analysis, US and Europe, 2014
- Total Diabetes Diagnostics Market: Percent Revenue Breakdown, US and Europe, 2014
- Total Diabetes Diagnostics Market: Competitive Segment Analysis, US and Europe, 2014
- Total Diabetes Diagnostics Market: Market Outlook, US and Europe, 2014 and 2024
- Total Diabetes Diagnostics Market: Competitive Landscape, US and Europe, 2014
- Total Diabetes Diagnostics Market: Game-changing Strategies, US and Europe, 2014
- Total Diabetes Diagnostics Market: Top Product Analysis, US and Europe, 2014
- Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
- Total Diabetes Diagnostics Market: Revenue Forecast, US and Europe, 2011-2020
- Total Diabetes Diagnostics Market by Segment: Percent Sales Breakdown, US and Europe, 2014
- Total Diabetes Diagnostics Market: Percent Sales Breakdown, US and Europe, 2020
- Total Diabetes Diagnostics Market: Revenue Forecast by Segment, US and Europe, 2011-2020
- Diabetes Diagnostics Market: Key Market Drivers, US, 2015-2020
- Diabetes Diagnostics Market: Key Market Restraints, US, 2015-2020
- Diabetes Diagnostics Market: Market Engineering Measurements, US, 2014
- Diabetes Diagnostics Market: Revenue Forecast, US, 2011-2020
- Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2014
- Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2020
- Diabetes Diagnostics Market: Revenue Forecast by Segment, US, 2011-2020
- SMBG Segment: Market Engineering Measurements, US, 2014
- SMBG Segment: Revenue Forecast, US, 2011-2020
- SMBG Segment: Revenue Forecast by Sub-Segment, US, 2011-2020
- SMBG Segment: Percent Revenue Breakdown, US, 2014
- SMBG Segment: Market Positions of the Leading Participants, US, 2014
- POCT Segment: Market Engineering Measurements, US, 2014
- POCT Segment: Revenue Forecast, US, 2011-2020
- POCT Segment: Revenue Forecast by Sub-Segment, US, 2011-2020
- POCT Segment: Percent Revenue Breakdown, US, 2014
- Lab-based HbA1c Testing Segment: Market Engineering Measurements, US, 2014
- Lab-based HbA1c Testing Segment: Revenue Forecast, US, 2011-2020
- Lab-based Testing Segment: Percent Revenue Breakdown, US, 2014
- Diabetes Diagnostics Market: Trends of Lab-based Tests, US, 2014
- FPG Testing Market: Market Potential, US, 2014
- OGTT Testing Market: Market Potential, US, 2014
- HbA1c Testing Market: Market Potential, US, 2014
- Microalbumin Market: Market Potential, US, 2014
- Diabetes Diagnostics Market: Market Engineering Measurements, Europe, 2014
- Diabetes Diagnostics Market: Revenue Forecast, Europe, 2011-2020
- Diabetes Diagnostics Market: Revenue Forecast by Segment, Europe, 2011-2020
- Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2014
- Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2020
- SMBG Segment: Market Engineering Measurements, Europe, 2014
- Diabetes Diagnostics Market: SMBG Revenue Forecast, Europe, 2011-2020
- SMBG Segment: Revenue Forecast, Europe, 2011-2020
- SMBG Segment: Percent Revenue Breakdown, Europe, 2014
- POCT Segment: Market Engineering Measurements, Europe, 2014
- POCT Segment: Revenue Forecast, Europe, 2011-2020
- POCT Segment: Revenue Forecast by Segment, Europe, 2011-2020
- POCT segment: Percent Revenue Breakdown, Europe, 2014
- Lab-based HbA1c Testing Segment: Market Engineering Measurements, Europe, 2014
- Lab-based HbA1c Testing Segment: Revenue Forecast, Europe, 2011-2020
- Lab-based Testing Segment: Percent Revenue Breakdown, Europe, 2014
- Diabetes Diagnostics Market: Trends of Lab-based Tests, Europe, 2014
- FPG Testing Market: Market Potential, Europe, 2014
- OGTT Testing Market: Market Potential, Europe, 2014
- HbA1c Testing Market: Market Potential, Europe, 2014
- Microalbumin Market: Market Potential, Europe, 2014
- Diabetes Diagnostics Market: Percent Sales breakdown by Region, Europe, 2014
- Diabetes Diagnostics Market: Revenue Forecast, UK, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, UK, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, UK, 2011-2020
- Diabetes Diagnostics Market: Impact of Top 10 Trends, UK, 2014
- Diabetes Diagnostics Market: Revenue Forecast, Germany, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, Germany, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, Germany, 2011-2020
- Diabetes Diagnostics Market: Impact of Top 10 Trends, Germany, 2014
- Diabetes Diagnostics Market: Revenue Forecast, France, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, France, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, France, 2011-2020
- Diabetes Diagnostics Market: Impact of Top 10 Trends, France, 2014
- Diabetes Diagnostics Market: Revenue Forecast, Italy, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, Italy, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, Italy, 2011-2020
- Diabetes Diagnostics Market: Impact of Top 10 Trends, Italy, 2014
- Diabetes Diagnostics Market: Revenue Forecast, Spain, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, Spain, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, Spain, 2011-2020
- Diabetes Diagnostics Market: Impact of Top 10 Trends, Spain, 2014
- Diabetes Diagnostics Market: Revenue Forecast, Benelux, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, Benelux, 2014
- Diabetes Diagnostics Market: Demographic Information, the Netherlands, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, Benelux, 2011-2020
- Diabetes Diagnostics Market: Revenue Forecast, Scandinavia, 2011-2020
- Diabetes Diagnostics Market: Demographic Information, Scandinavia, 2014
- Diabetes Diagnostics Market: Revenue Forecast by Segment, Scandinavia, 2011-2020
- Diabetes Diagnostics Market: Impact of Top 10 Trends, Benelux and Scandinavia, 2014
